No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Positive CHMP Opinion for Celltrion’s Omalizumab Autoinjector
Korea Medical Review reported on 31 March 2025 that Celltrion has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) regarding its autoinjector formulation of Omlyclo®, biosimilar to Genentech/Novartis’ Xolair® (omalizumab)…